Correlation Between Syros Pharmaceuticals and Surface Oncology
Can any of the company-specific risk be diversified away by investing in both Syros Pharmaceuticals and Surface Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Syros Pharmaceuticals and Surface Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Syros Pharmaceuticals and Surface Oncology, you can compare the effects of market volatilities on Syros Pharmaceuticals and Surface Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Syros Pharmaceuticals with a short position of Surface Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Syros Pharmaceuticals and Surface Oncology.
Diversification Opportunities for Syros Pharmaceuticals and Surface Oncology
-0.21 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Syros and Surface is -0.21. Overlapping area represents the amount of risk that can be diversified away by holding Syros Pharmaceuticals and Surface Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Surface Oncology and Syros Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Syros Pharmaceuticals are associated (or correlated) with Surface Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Surface Oncology has no effect on the direction of Syros Pharmaceuticals i.e., Syros Pharmaceuticals and Surface Oncology go up and down completely randomly.
Pair Corralation between Syros Pharmaceuticals and Surface Oncology
Given the investment horizon of 90 days Syros Pharmaceuticals is expected to under-perform the Surface Oncology. In addition to that, Syros Pharmaceuticals is 1.69 times more volatile than Surface Oncology. It trades about -0.01 of its total potential returns per unit of risk. Surface Oncology is currently generating about 0.03 per unit of volatility. If you would invest 88.00 in Surface Oncology on August 30, 2024 and sell it today you would earn a total of 8.00 from holding Surface Oncology or generate 9.09% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 31.31% |
| Values | Daily Returns |
Syros Pharmaceuticals vs. Surface Oncology
Performance |
| Timeline |
| Syros Pharmaceuticals |
| Surface Oncology |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Syros Pharmaceuticals and Surface Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Syros Pharmaceuticals and Surface Oncology
The main advantage of trading using opposite Syros Pharmaceuticals and Surface Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Syros Pharmaceuticals position performs unexpectedly, Surface Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Surface Oncology will offset losses from the drop in Surface Oncology's long position.| Syros Pharmaceuticals vs. Surrozen | Syros Pharmaceuticals vs. Bolt Biotherapeutics | Syros Pharmaceuticals vs. Larimar Therapeutics | Syros Pharmaceuticals vs. Keros Therapeutics |
| Surface Oncology vs. Syros Pharmaceuticals | Surface Oncology vs. Repare Therapeutics | Surface Oncology vs. Personalis | Surface Oncology vs. Evogene |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Complementary Tools
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |